Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 16, 2022

SELL
$0.41 - $0.91 $4,492 - $9,970
-10,957 Closed
0 $0
Q1 2022

May 17, 2022

SELL
$0.79 - $1.59 $18,595 - $37,425
-23,538 Reduced 68.24%
10,957 $9,000
Q4 2021

Feb 15, 2022

SELL
$1.36 - $2.94 $36,660 - $79,250
-26,956 Reduced 43.87%
34,495 $47,000
Q3 2021

Nov 16, 2021

SELL
$2.97 - $4.84 $13,789 - $22,472
-4,643 Reduced 7.02%
61,451 $185,000
Q2 2021

Aug 16, 2021

SELL
$3.71 - $5.13 $251,430 - $347,665
-67,771 Reduced 50.63%
66,094 $305,000
Q1 2021

May 18, 2021

BUY
$4.08 - $14.75 $387,473 - $1.4 Million
94,969 Added 244.16%
133,865 $575,000
Q4 2020

Feb 17, 2021

SELL
$11.06 - $14.01 $569,534 - $721,444
-51,495 Reduced 56.97%
38,896 $430,000
Q3 2020

Nov 17, 2020

BUY
$10.26 - $14.55 $735,734 - $1.04 Million
71,709 Added 383.84%
90,391 $1.09 Million
Q2 2020

Aug 17, 2020

BUY
$7.11 - $13.76 $132,829 - $257,064
18,682 New
18,682 $257,000
Q1 2020

May 15, 2020

SELL
$5.71 - $15.85 $173,309 - $481,079
-30,352 Closed
0 $0
Q4 2019

Feb 14, 2020

BUY
$9.6 - $17.75 $131,203 - $242,589
13,667 Added 81.91%
30,352 $463,000
Q3 2019

Nov 14, 2019

BUY
$12.16 - $21.0 $202,889 - $350,385
16,685 New
16,685 $203,000
Q2 2018

Aug 15, 2018

SELL
$15.88 - $19.5 $194,291 - $238,582
-12,235 Closed
0 $0
Q1 2018

May 15, 2018

BUY
$13.53 - $17.47 $165,539 - $213,745
12,235 New
12,235 $208,000

Others Institutions Holding ATNX

About Athenex, Inc.


  • Ticker ATNX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 156,790,000
  • Market Cap $1.57M
  • Description
  • Athenex, Inc., a biopharmaceutical company, engages in the discovery, development, and commercialization of drugs for the treatment of cancer. It operates through three segments: Oncology Innovation Platform, Global Supply Chain Platform, and Commercial Platform. The company's Orascovery product candidates include Oral paclitaxel and encequidar,...
More about ATNX
Track This Portfolio

Track Jane Street Group, LLC Portfolio

Follow Jane Street Group, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Jane Street Group, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jane Street Group, LLC with notifications on news.